Medical Societies Issue Joint Statement in Face of Possible Stockout of Abraxane, Calling for Continued Treatment

Taiho Pharmaceutical said on August 26 in a statement addressed to patients and their families that its anticancer agent Abraxane IV Infusion 100 mg (paclitaxel) is likely to face a stockout around the middle of October. In response, medical societies...read more